Cryptorchidism Prevalence
Cryptorchidism Prevalence - Related Videos
01:08
Prevalence and Incidence
0 Views •
2025
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions. Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
07:35
Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
0 Views •
Cited by 4 •
2020
The presented diagnostic FL-DNA kit is a time-saving and user-friendly method to determine the reliable probability of the presence of colorectal cancer lesions.
13:02
The Terroir Concept Interpreted through Grape Berry Metabolomics and Transcriptomics
0 Views •
Cited by 10 •
2016
This article describes the application of untargeted metabolomics, transcriptomics and multivariate statistical analysis to grape berry transcripts and metabolites in order to gain insight into the terroir concept, i.e., the impact of the environment on berry quality traits.
02:16
Measures of Central Tendency
0 Views •
2020
The "center" of a data set is also a way of describing location. The two most widely used measures of the "center" of the data are the mean (average) and the median. The words "mean" and "average" are often used interchangeably. The substitution of one word for the other is common practice. The technical term is "arithmetic mean" and "average" is technically a center location. However, in practice among non-statisticians, "average" is commonly accepted for "arithmetic mean." Another measure of...
12:08
Improving IV Insulin Administration in a Community Hospital
0 Views •
Cited by 7 •
2012
When compared to the previous paper protocol, implementation of a computerized glucose management system results in a substantial increase in blood glucose concentration measurements within the target range. Using a computerized glucose management system to monitor blood glucose levels, decreases in severe hypoglycemia (<40 mg/dL), clinical hypoglycemia (<70 mg/dL), and hyperglycemia (>180 mg/dL) also can be observed.
FAQs
Gestational age changes how prevalence should be interpreted because estimates may differ between populations assessed at different stages of development. A study of infants born at varying gestational ages is not directly equivalent to one using a uniform age group. Reporting gestational age helps distinguish population composition from possible regional, environmental, genetic, or healthcare-related influences.
Assessment timing matters because some affected testes descend spontaneously after birth. An estimate obtained shortly after delivery can therefore differ from one made later, even when the underlying populations are similar. Studies should state when examinations occurred so readers can interpret whether observed differences reflect postnatal change, contrasting follow-up periods, or other population factors.
Prevalence comparisons depend on which findings a study counts and how consistently those findings are identified. Researchers may need to distinguish cases involving one testis from those involving both, while applying the same criteria across the population. Clear diagnostic definitions make estimates more comparable and reduce the chance that apparent geographic or age-related differences result from classification practices.
Researchers estimate prevalence through physical examination, medical records, or population surveillance. These approaches provide different ways to identify affected individuals, so the selected data source should be reported alongside the estimate. Recording the method allows readers to judge whether results from separate studies are reasonably comparable and helps interpret variation related to assessment practices or healthcare documentation.
Comparing regions and age groups can reveal patterns in the condition and generate evidence about factors that may influence those patterns. Researchers can examine whether differences align with genetic, environmental, or healthcare-related influences, while considering gestational age, assessment timing, and diagnostic criteria. These comparisons are most informative when the populations and measurement methods are clearly described.
Prevalence data help with clinical planning and follow-up of affected infants by showing how frequently the condition occurs in defined populations. They also guide research into possible consequences, including impaired fertility and testicular malignancy. Because spontaneous postnatal descent can alter estimates, longitudinal or age-specific interpretation is important when connecting prevalence patterns with clinical needs and outcomes.